Introduction to mycoplasma and cell product risks

In this webinar, Dr Tim Sandle introduces mycoplasmas and outlines the risks they present and the remediation strategies required to control the microorganisms.

 

Mycoplasma species are the most common contaminants in cellular therapies. This webinar introduces mycoplasmas and outlines the risks they present and the remediation strategies required to control the microorganisms.

 

At RSSL, we carry out Mycoplasma testing as part of our Biosafety and release testing service in line with the international regulatory guidelines. Get in touch to find out more

Send us an enquiry
+44 (0) 118 918 4000
lifesciencesales@rssl.com
Send an enquiry Send an enquiry
Topic areas we cover include:
  • Risks posed to cellular products
  • Sterile filtration challenges
  • Surface adherence challenges
  • Sources of contamination including association with cell culture reagents
  • Remediation strategies, including donor material assessment
  • Regulations

Register for this on demand webinar

Register now Register now
About the speaker:

 

 

Dr. Tim Sandle has over twenty-five years’ experience of microbiological research and biopharmaceutical processing. He is a member of several editorial boards and he has written over six hundred book chapters, peer reviewed papers and technical articles relating to microbiology. Dr. Sandle works for a pharmaceutical manufacturer in the UK, and is a visiting tutor at both the University of Manchester and UCL.

Need to contact us? Get help or ask us a question

Send an enquiry Send an enquiry